Original Articles
Vol. 19 No. 4 (2025)
The impact of diabetes on the outcomes of lower extremity arterial disease in patients with vascular surgical interventions in Kosovo
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 24 September 2025
188
Views
116
Downloads
Authors
The study aims to enhance understanding of the link between type 2 diabetes mellitus (DM) and lower extremity arterial disease (LEAD) outcomes in patients treated with vascular surgical interventions to improve clinical practice and management. It includes patients with DM who underwent surgery for LEAD from November 2023 to April 2024 at the Vascular Surgery Clinic, University Clinical Center of Kosovo, Pristina. Data were collected from medical records and included demographics, comorbidities, smoking status, laboratory values, procedural details, outcomes, prior surgeries, and hospitalization duration. Categorical variables were analyzed using descriptive statistics, one-sample t-tests, bivariate, and chi-square tests. Ethical approval was obtained, and informed consent was secured. The largest patient group was aged 62-71 years (48.15%), predominantly male (62.96%), and mostly insulin-managed (96.3%). Ischemic toe gangrene requiring amputation occurred in 25.93% of cases; arterial ischemia with thrombosis was the most common preoperative complication (33.33%). Hospitalization was typically 6-10 days (40.74%), with combined anti-aggregation, anti-diabetic, and antibiotic therapy used in 81.48% of cases. LEAD remains a major global health concern, requiring personalized care strategies and ongoing patient education to reduce complications and amputations.
Downloads
Download data is not yet available.
Citations
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Tasc II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45:S5-67. DOI: https://doi.org/10.1016/j.jvs.2006.12.037
Cangiano G, Corvino F, Giurazza F, et al. Percutaneous deep foot vein arterialization IVUS-guided in no-option critical limb ischemia diabetic patients. Vasc Endovascular Surg 2021;55:58-63. DOI: https://doi.org/10.1177/1538574420965743
Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 2019;7:e1020-30. DOI: https://doi.org/10.1016/S2214-109X(19)30255-4
Aboyans V, Ricco JB, Bartelink ML, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Polish Heart J 2017;75:1065-160. DOI: https://doi.org/10.5603/KP.2017.0216
Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1· 9 million people. Lancet Diabetes Endocrinol 2015;3:105-13. DOI: https://doi.org/10.1016/S2213-8587(14)70219-0
Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017;69:e71-126.
Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013;382:1329-40. DOI: https://doi.org/10.1016/S0140-6736(13)61249-0
Al Rifai M, Blaha MJ, Nambi V, et al. Determinants of incident atherosclerotic cardiovascular disease events among those with absent coronary artery calcium: multi-ethnic study of atherosclerosis. Circulation 2022;145:259-67. DOI: https://doi.org/10.1161/CIRCULATIONAHA.121.056705
Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg 2019;58:S1-109.e33.
Martí-Fàbregas J, Delgado-Mederos R, Mateo J. Limitaciones del tratamiento anticoagulante. Neurologia 2012;27:27-32. [Article in Spanish]. DOI: https://doi.org/10.1016/S0213-4853(12)70005-1
Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110:738-43. DOI: https://doi.org/10.1161/01.CIR.0000137913.26087.F0
Armstrong DG, Boulton AJ, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017;376:2367-75. DOI: https://doi.org/10.1056/NEJMra1615439
Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes—a review. Diabet Med 2010;27:4-14. DOI: https://doi.org/10.1111/j.1464-5491.2009.02866.x
American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003;26:3333-41. DOI: https://doi.org/10.2337/diacare.26.12.3333
Mills Sr JL, Conte MS, Armstrong DG, et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014;59:220-34.e1-2. DOI: https://doi.org/10.1016/j.jvs.2013.08.003
Khera R, Clark C, Lu Y, et al. Association of angiotensin converting enzyme inhibitors and angiotensin receptor blockers with the risk of hospitalization and death in hypertensive patients with COVID 19. J Am Heart Assoc 2021;10:e018086. DOI: https://doi.org/10.1161/JAHA.120.018086
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111-88. DOI: https://doi.org/10.1093/eurheartj/ehz455
Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2008;52:1502-17. DOI: https://doi.org/10.1016/j.jacc.2008.08.002
Ku EJ, Kim B, Han K, Lee SH, Kwon HS. Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT. Cardiovasc Diabetol 2024;23:329. DOI: https://doi.org/10.1186/s12933-024-02422-9
Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 2017;376:1713-22. DOI: https://doi.org/10.1056/NEJMoa1615664
Hankey GJ. Antithrombotic therapy for stroke prevention: what’s new? Circulation 2019;139:1131-3. DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.036656
Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 2017;377:1319-30. DOI: https://doi.org/10.1056/NEJMoa1709118
Patoulias D, Doumas M, Papadopoulos C, Karagiannis A. Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials. Clin Rheumatol 2021;40:4671-4. DOI: https://doi.org/10.1007/s10067-021-05884-4
Moxey PW, Hofman D, Hinchliffe RJ, et al. Volume–outcome relationships in lower extremity arterial bypass surgery. Ann Surg 2012;256:1102-7. DOI: https://doi.org/10.1097/SLA.0b013e31825f01d1
Ferraresi R, Ucci A, Pizzuto A, et al. A novel scoring system for small artery disease and medial arterial calcification is strongly associated with major adverse limb events in patients with chronic limb-threatening ischemia. J Endovasc Ther 2021;28:194-207. DOI: https://doi.org/10.1177/1526602820966309
Marcolino MS, Ziegelmann PK, Souza-Silva MV, et al. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: results from the Brazilian COVID-19 registry. Int J Infect Dis 2021;107:300-10. DOI: https://doi.org/10.1016/j.ijid.2021.01.019
Pastori D, Farcomeni A, Milanese A, et al. Statins and major adverse limb events in patients with peripheral artery disease: a systematic review and meta-analysis. Thromb Haemost 2020;120:866-75. DOI: https://doi.org/10.1055/s-0040-1709711
Long CA, Mulder H, Fowkes FG, et al. Incidence and factors associated with major amputation in patients with peripheral artery disease: insights from the EUCLID trial. Circ Cardiovasc Qual Outcomes 2020;13:e006399. DOI: https://doi.org/10.1161/CIRCOUTCOMES.119.006399
Conte MS. Appropriate use of revascularization for claudication. J Vasc Surg 2020;71:131. DOI: https://doi.org/10.1016/j.jvs.2019.05.032
Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e686-725. DOI: https://doi.org/10.1161/CIR.0000000000000501
Espada CL, Behrendt CA, Mani K, et al. Editor's choice–the VASCUNExplanT project: an international study assessing open surgical conversion of failed non-infected endovascular aortic aneurysm repair. Eur J Vasc Endovasc Surg 2023;66:653-60. DOI: https://doi.org/10.1016/j.ejvs.2023.07.029
Wang W, Zhao T, Geng K, et al. Smoking and the pathophysiology of peripheral artery disease. Front Cardiovasc Med 2021;8:704106. DOI: https://doi.org/10.3389/fcvm.2021.704106
Wang JL, Yin WJ, Zhou LY, Wang YF, Zuo XC. Association between initiation, intensity, and cessation of smoking and mortality risk in patients with cardiovascular disease: a cohort study. Front Cardiovasc Med 2021;8:728217. DOI: https://doi.org/10.3389/fcvm.2021.728217
Betesh-Abay B, Shiyovich A, Plakht Y. Social support and 10-year mortality following acute myocardial infarction. J Cardiovasc Dev Dis 2025;12:147. DOI: https://doi.org/10.3390/jcdd12040147
Kirkman MS, Mahmud H, Korytkowski MT. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes mellitus. Endocrinol Metab Clin North Am 2018;47:81-96. DOI: https://doi.org/10.1016/j.ecl.2017.10.002
Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89. DOI: https://doi.org/10.1056/NEJMoa0806470
Fokkenrood HJP, Bendermacher BL, Lauret GJ, et al. Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev 2018;4:CD005263. DOI: https://doi.org/10.1002/14651858.CD005263.pub4
Kourek C, Georgopoulou M, Kolovou K, et al. Intensive care unit hyperglycemia after cardiac surgery: risk factors and clinical outcomes. J Cardiothorac Vasc Anesth 2024;38:162-9. DOI: https://doi.org/10.1053/j.jvca.2023.09.022
Palomar-Cros A, Andreeva VA, Fezeu LK, et al. Dietary circadian rhythms and cardiovascular disease risk in the prospective NutriNet-Santé cohort. Nat Commun 2023;14:7899. DOI: https://doi.org/10.1038/s41467-023-43444-3
Fitridge R, Chuter V, Mills J, et al. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer. Diabetes Metab Res Rev 2024;40:e3686. DOI: https://doi.org/10.1002/dmrr.3686
Lungu CN, Creteanu A, Mehedinti MC. Endovascular drug delivery. Life 2024;14:451. DOI: https://doi.org/10.3390/life14040451
Saber H, Froehler MT, Zaidat OO, et al. Variation in vessel size and angiographic outcomes following stent‐retriever thrombectomy in acute ischemic stroke: STRATIS Registry. Stroke Vasc Interven Neurol 2024;4:3. DOI: https://doi.org/10.1161/SVIN.123.000978
Sharma G, Scully RE, Shah SK, et al. Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg 2018;68:1796-804.e2. DOI: https://doi.org/10.1016/j.jvs.2018.01.067
Hess CN, Norgren L, Ansel GM, et al. A structured review of antithrombotic therapy in peripheral artery disease with a focus on revascularization: a TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) initiative. Circulation 2017;135:2534-55. DOI: https://doi.org/10.1161/CIRCULATIONAHA.117.024469
Mueller AM, Langwieser N, Bradaric C, et al. Endovascular treatment for steno-occlusive iliac artery disease: safety and long-term outcome. Angiology 2018;69:308-15. DOI: https://doi.org/10.1177/0003319717720052
Khan MS, Zou F, Khan AR, et al. Meta-analysis comparing endovascular treatment modalities for femoropopliteal peripheral artery disease. Am J Cardiol 2020;128:181-8. DOI: https://doi.org/10.1016/j.amjcard.2020.05.015
Anand SS, Caron F, Eikelboom JW, et al. Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial. J Am Coll Cardiol 2018;71:2306-15. DOI: https://doi.org/10.1016/j.jacc.2018.03.008
Alon L, Corica B, Raparelli V, et al. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Prev Cardiol 2022;29:938-46. DOI: https://doi.org/10.1093/eurjpc/zwab212
Basili S, Romiti GF, Cangemi R, Corica B. Lesson learned from the COMPASS and VOYAGER PAD trials: dual pathway inhibition as a new antithrombotic paradigm? Eur J Prev Cardiol 2022;29:e178-80. DOI: https://doi.org/10.1093/eurjpc/zwab137
How to Cite
The impact of diabetes on the outcomes of lower extremity arterial disease in patients with vascular surgical interventions in Kosovo. (2025). Italian Journal of Medicine, 19(4). https://doi.org/10.4081/itjm.2025.2095
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.